{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:20:42Z","timestamp":1787170842038,"version":"build-2736575974"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00993","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:42:11Z","timestamp":1591058531000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Allogenic Adipose Tissue-Derived Stromal\/Stem Cells and Vitamin D Supplementation in Patients With Recent-Onset Type 1 Diabetes Mellitus: A 3-Month Follow-Up Pilot Study"],"prefix":"10.3389","volume":"11","author":[{"given":"Debora B.","family":"Araujo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana R.","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora L.","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de F\u00e1tima C.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica P.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronir R.","family":"Luiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar S.","family":"Claudio-Da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A. L.","family":"Gabbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Dib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E. B.","family":"Couri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Maiolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen L. K.","family":"Rebelatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora R.","family":"Daga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra C.","family":"Senegaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo R. S.","family":"Brofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandra Santos","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 E. P.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenita","family":"Zajdenverg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Rodacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(01)05415-0","article-title":"Type 1 diabetes: new perspectives on disease pathogenesis and treatment","volume":"358","author":"Atkinson","year":"2001","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.2337\/diabetes.54.suppl_2.S25","article-title":"Natural history of type 1 diabetes","volume":"54","author":"Achenbach","year":"2005","journal-title":"Diabetes."},{"key":"B3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s11892-012-0309-0","article-title":"Risks, benefits, and therapeutic potential of hematopoietic stem cell transplantation for autoimmune diabetes","volume":"12","author":"Couri","year":"2012","journal-title":"Curr Diabetes Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.diabres.2012.12.019","article-title":"Continuous C-peptide loss in patients with type 1 diabetes and multiethnic background","volume":"99","author":"Dantas","year":"2013","journal-title":"Diabetes Res Clin Pract."},{"key":"B5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1590\/S0004-27302008000200020","article-title":"A secre\u00e7\u00e3o residual do pept\u00eddeo C faz diferen\u00e7a no tratamento do diabetes melito tipo 1?","volume":"52","author":"Rodacki","year":"2008","journal-title":"Arq Bras Endocrinol Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1210\/er.2011-0008","article-title":"Immunological applications of stem cells in type 1 diabetes","volume":"32","author":"Fiorina","year":"2011","journal-title":"Endocr Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrendo.2012.237","article-title":"Immune therapy in type 1 diabetes mellitus","volume":"9","author":"Lernmark","year":"2013","journal-title":"Nat Rev Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"838","DOI":"10.4161\/hv.26890","article-title":"Non-antigenic and antigenic interventions in type 1 diabetes","volume":"10","author":"Ryd\u00e9n","year":"2014","journal-title":"Hum Vaccines Immunother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1517\/13543784.2015.1075973","article-title":"Immunotherapies currently in development for the treatment of type 1 diabetes","volume":"24","author":"Davis","year":"2015","journal-title":"Expert Opin Invest Drugs."},{"key":"B10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1517\/14712598.2014.881797","article-title":"Treatment of new onset type 1 diabetes with teplizumab: successes and pitfalls in development","volume":"14","author":"Vudattu","year":"2014","journal-title":"Expert Opin Biol Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.beha.2004.04.004","article-title":"Coincidental autoimmune disease in patients transplanted for conventional indications","volume":"17","author":"Marmont","year":"2004","journal-title":"Best Pract Res Clin Haematol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jaut.2016.05.002","article-title":"Regulatory mechanisms of immune tolerance in type 1 diabetes and their failures","volume":"71","author":"Kuhn","year":"2016","journal-title":"J Autoimmun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1038\/cti.2015.43","article-title":"Treg activation defect in type 1 diabetes: correction with TNFR2 agonism","volume":"5","author":"Okubo","year":"2016","journal-title":"Clin Trans Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/sji.12418","article-title":"Analyses of regulatory CD4 + CD25 + FOXP3 + T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children","volume":"83","author":"Hamari","year":"2016","journal-title":"Scand J Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2337\/db08-0180","article-title":"Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes","volume":"57","author":"Abdi","year":"2008","journal-title":"Diabetes."},{"key":"B17","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1073\/pnas.0608249103","article-title":"Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice","volume":"103","author":"Lee","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3109\/14653240902981144","article-title":"An alternative method for the isolation of mesenchymal stromal cells derived from lipoaspirate samples","volume":"11","author":"Baptista","year":"2009","journal-title":"Cytotherapy."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","article-title":"A phase I clinical trial of the treatment of crohn's fistula by adipose mesenchymal stem cell transplantation: diseases of the colon & rectum","volume":"48","author":"Garc\u00eda-Olmo","year":"2005","journal-title":"Dis Colon Rectum."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.3892\/etm.2018.6769","article-title":"Stem cell transplantation for the treatment of patients with type1 diabetes mellitus: a meta-analysis","volume":"16","author":"Gan","year":"2018","journal-title":"Exp Ther Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/14712598.2019.1563069","article-title":"An updated review of adipose derived-mesenchymal stem cells and their applications in musculoskeletal disorders","volume":"19","author":"Rivera-Izquierdo","year":"2019","journal-title":"Expert Opin Biol Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s11605-018-3895-6","article-title":"A step-by-step surgical protocol for the treatment of perianal fistula with adipose-derived mesenchymal stem cells","volume":"22","author":"Georgiev-Hristov","year":"2018","journal-title":"J Gastrointest Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3727\/096368916X691998","article-title":"Autologous adipose-derived mesenchymal stromal cells for the treatment of psoriasis vulgaris and psoriatic arthritis: a case report","volume":"25","author":"De Jesus","year":"2016","journal-title":"Cell Transplant."},{"key":"B24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12016-016-8552-9","article-title":"Adipose-derived mesenchymal stem cells in autoimmune disorders: state of the art and perspectives for systemic sclerosis","volume":"52","author":"Maria","year":"2017","journal-title":"Clin Rev Allergy Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.retram.2016.10.006","article-title":"Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients","volume":"65","author":"Daumas","year":"2017","journal-title":"Curr Res Transl Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1210\/en.2002-220449","article-title":"1,25-dihydroxy vitamin D 3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein a20","volume":"143","author":"Riachy","year":"2002","journal-title":"Endocrinology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/pedi.12342","article-title":"Low vitamin D level in pediatric patients with new onset type 1 diabetes is common, especially if in ketoacidosis: Vitamin D in new onset Type 1 Diabetes","volume":"17","author":"Al-Zubeidi","year":"2016","journal-title":"Pediatr Diabetes."},{"key":"B28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.clim.2015.08.002","article-title":"Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - a randomized clinical trial","volume":"161","author":"Treiber","year":"2015","journal-title":"Clin Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1900\/RDS.2017.14.260","article-title":"The effects of vitamin D supplementation in newly diagnosed type 1 diabetes patients: systematic review of randomized controlled trials","volume":"14","author":"Gregoriou","year":"2017","journal-title":"Rev Diabet Stud."},{"key":"B30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/archpediatrics.2012.164","article-title":"Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual \u03b2-cell function in new-onset type 1 diabetes mellitus","volume":"166","author":"Gabbay","year":"2012","journal-title":"Arch Pediatr Adol Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/pedi.12105","article-title":"No association between type 1 diabetes and genetic variation in vitamin D metabolism genes: a Danish study: T1D and SNPs in vitamin D metabolism genes","volume":"15","author":"Thorsen","year":"2014","journal-title":"Pediatr Diabetes."},{"key":"B32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.diabet.2008.10.003","article-title":"Mesenchymal stem cells: stem cell therapy perspectives for type 1 diabetes","volume":"35","author":"Vija","year":"2009","journal-title":"Diabetes Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2337\/dc15-0171","article-title":"Umbilical cord mesenchymal stromal cell with autologous bone marrow cell transplantation in established type 1 diabetes: a pilot randomized controlled open-label clinical study to assess safety and impact on insulin secretion","volume":"39","author":"Cai","year":"2016","journal-title":"Diabetes Care."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.transproceed.2008.03.113","article-title":"Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin","volume":"40","author":"Trivedi","year":"2008","journal-title":"Transpl Proc."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1001\/jama.297.14.1568","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"297","author":"Voltarelli","year":"2007","journal-title":"JAMA."},{"key":"B36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.18544\/PEDM-22.02.0053","article-title":"Department of pediatrics, the upper silesian child health center, the honeymoon phase - what we know today about the factors that can modulate the remission period in type 1 diabetes","volume":"22","author":"Soko\u0142owska","year":"2016","journal-title":"Pediatr Endocr Diabetes Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"CD008101","DOI":"10.1002\/14651858.CD008101.pub2","article-title":"Continuous glucose monitoring systems for type 1 diabetes mellitus","volume":"1","author":"Langendam","year":"2012","journal-title":"Cochrane Datab Syst Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1089\/dia.2012.0303","article-title":"Evaluation of the mean absolute glucose change as a measure of glycemic variability using continuous glucose monitoring data","volume":"15","author":"Kohnert","year":"2013","journal-title":"Diabetes Technol Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1089\/dia.2010.0247","article-title":"Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups","volume":"13","author":"Hill","year":"2011","journal-title":"Diabetes Technol Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.2337\/dc13-2042","article-title":"Nutrition therapy recommendations for the management of adults with diabetes","volume":"36","author":"Evert","year":"2013","journal-title":"Diabetes Care."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e19319","DOI":"10.1097\/MD.0000000000019319","article-title":"Diabetes mellitus as a risk factor for retinal vein occlusion: a meta-analysis","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine."},{"key":"B43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/IAE.0000000000001122","article-title":"Posterior eye segment complications related to allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Yoo","year":"2017","journal-title":"Retina"},{"key":"B44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.14336\/AD.2019.0421","article-title":"The clinical efficacy and safety of stem cell therapy for diabetes mellitus: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2020","journal-title":"Aging Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1177\/0963689718763751","article-title":"Long-term effect of islet transplantation on glycemic variability","volume":"27","author":"Bertuzzi","year":"2018","journal-title":"Cell Transplant."},{"key":"B46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3324\/haematol.2009.017038","article-title":"Stem cell transplantation for autoimmune diseases","volume":"95","author":"Hugle","year":"2010","journal-title":"Haematologica."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1172\/JCI134057","article-title":"High residual C-peptide likely contributes to glycemic control in type 1 diabetes","volume":"130","author":"Rickels","year":"2020","journal-title":"J Clin Invest."},{"key":"B48","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/pedi.12061","article-title":"Pediatric diabetes consortium type 1 diabetes new onset (NeOn) study: factors associated with HbA1c levels one year after diagnosis: characteristics associated with HbA1c","volume":"15","author":"Redondo","year":"2014","journal-title":"Pediatr Diabetes."},{"key":"B49","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.it.2019.04.005","article-title":"Regulatory immune mechanisms beyond regulatory T cells","volume":"40","author":"Christoffersson","year":"2019","journal-title":"Trends Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1172\/JCI23961","article-title":"TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs","volume":"115","author":"Bisikirska","year":"2005","journal-title":"J Clin Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.2337\/db13-0236","article-title":"Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Prot\u00e9g\u00e9 trial","volume":"62","author":"Hagopian","year":"2013","journal-title":"Diabetes."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.2337\/dc13-0327","article-title":"Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes","volume":"37","author":"Aronson","year":"2014","journal-title":"Diabetes Care."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00993\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:42:14Z","timestamp":1591058534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00993\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2020.00993"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00993","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"article-number":"993"}}